Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Neurocentrx Pharma Pty Ltd

Clinical trials sponsored by Neurocentrx Pharma Pty Ltd, explained in plain language.

Not yet recruiting 1

Could a new oral ketamine capsule ease bipolar depression when other treatments fail?

Symptom relief Not yet recruiting

This study tests an oral ketamine capsule (KET-AD) designed to be abuse-deterrent in adults with treatment-resistant bipolar depression. About 160 participants will receive either KET-AD or a placebo, taken three times a week for up to 7 weeks, alongside their usual treatment. Th…

Phase 2 • Sponsor: Neurocentrx Pharma Pty Ltd • Aim: Symptom relief

Last updated Jun 27, 2026 13:07 UTC